| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |